{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:51Z","timestamp":1786119291680,"version":"build-2736575974"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/hpc.0b013e31819a442a","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T03:18:04Z","timestamp":1243480684000},"page":"49-54","source":"Crossref","is-referenced-by-count":1,"title":["Clopidogrel in the Management of Acute Coronary Syndromes"],"prefix":"10.1097","volume":"8","author":[{"given":"Ezra A.","family":"Amsterdam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210126","first-page":"e25","article-title":"Heart disease and stroke statistics\u20132008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"R2-1-20210126","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jacc.2007.10.001","article-title":"2007 focused update of the ACC\/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"51","author":"Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R3-1-20210126","first-page":"e148","article-title":"ACC\/AHA 2007 Guidelines for the Management of Patients With Unstable Angina\/Non ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina\/Non ST-Elevation Myocardial Infarction).","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"R5-1-20210126","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-1-20210126","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"R7-1-20210126","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.amjcard.2007.09.089","article-title":"Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.","volume":"101","author":"Lev","year":"2008","journal-title":"Am J Cardiol"},{"key":"R8-1-20210126","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"R9-1-20210126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"R10-1-20210126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"R11-1-20210126","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes.","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"R12-1-20210126","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/jama.295.16.1912","article-title":"Association between hospital process performance and outcomes among patients with acute coronary syndromes.","volume":"295","author":"Peterson","year":"2006","journal-title":"JAMA"},{"key":"R14-1-20210126","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jacc.2004.11.055","article-title":"Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology\/American Heart Association Guidelines) National Quality Improvement Initiative.","volume":"45","author":"Blomkalns","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R15-1-20210126","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/01.CIR.0000157732.03358.64","article-title":"Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC\/AHA Guidelines?).","volume":"111","author":"Sonel","year":"2005","journal-title":"Circulation"},{"key":"R16-1-20210126","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ahj.2005.09.003","article-title":"Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines (CRUSADE).","volume":"152","author":"Cohen","year":"2006","journal-title":"Am Heart J"},{"key":"R17-1-20210126","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0828-282X(07)70876-0","article-title":"Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II.","volume":"23","author":"Zia","year":"2007","journal-title":"Can J Cardiol"},{"key":"R18-1-20210126","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjmed.2005.08.057","article-title":"Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.","volume":"119","author":"Han","year":"2006","journal-title":"Am J Med"},{"key":"R19-1-20210126","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.amjcard.2005.12.068","article-title":"Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes.","volume":"97","author":"Roe","year":"2006","journal-title":"Am J Cardiol"},{"key":"R20-1-20210126","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1001\/jama.292.17.2096","article-title":"Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.","volume":"292","author":"Bhatt","year":"2004","journal-title":"JAMA"},{"key":"R21-1-20210126","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/archinte.166.7.806","article-title":"Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.","volume":"166","author":"Tricoci","year":"2006","journal-title":"Arch Intern Med"},{"key":"R22-1-20210126","first-page":"196A","article-title":"Trends in the treatment and outcomes of patients with non-ST-segment elevation acute coronary syndromes managed medically without cardiac catheterization.","volume":"49","author":"Amsterdam","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R23-1-20210126","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ahj.2005.02.038","article-title":"Long-term adherence with cardiovascular drug regimens.","volume":"151","author":"Kulkarni","year":"2006","journal-title":"Am Heart J"},{"key":"R24-1-20210126","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"key":"R25-1-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"R26-1-20210126","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R27-1-20210126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"R28-1-20210126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2007.10.002","article-title":"2007 focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice guidelines.","volume":"51","author":"King","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R30-1-20210126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/hrt.2005.084830","article-title":"Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE).","volume":"93","author":"Fox","year":"2007","journal-title":"Heart"},{"key":"R31-1-20210126","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity.","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"key":"R32-1-20210126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2796.2002.01027.x","article-title":"Individual variations of platelet inhibition after loading doses of clopidogrel.","volume":"252","author":"Jaremo","year":"2002","journal-title":"J Intern Med"},{"key":"R33-1-20210126","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2004.09.067","article-title":"Variability in platelet responsiveness to clopidogrel among 544 individuals.","volume":"45","author":"Serebruany","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"R34-1-20210126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1538-7836.2007.02498.x","article-title":"Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection.","volume":"5","author":"Cattaneo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R35-1-20210126","doi-asserted-by":"crossref","first-page":"4N","DOI":"10.1016\/j.amjcard.2006.09.008","article-title":"Current options in platelet function testing.","volume":"98","author":"Michelson","year":"2006","journal-title":"Am J Cardiol"},{"key":"R36-1-20210126","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00000542-200610000-00011","article-title":"Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry.","volume":"105","author":"Agarwal","year":"2006","journal-title":"Anesthesiology"},{"key":"R37-1-20210126","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09537100701280654","article-title":"Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).","volume":"18","author":"Dyszkiewicz-Korpanty","year":"2007","journal-title":"Platelets"},{"key":"R38-1-20210126","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2007.11.065","article-title":"Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome.","volume":"101","author":"Frere","year":"2008","journal-title":"Am J Cardiol"},{"key":"R39-1-20210126","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/FPC.0b013e3282f1b2be","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G\/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.","volume":"17","author":"Giusti","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R41-1-20210126","doi-asserted-by":"crossref","first-page":"29J","DOI":"10.1016\/j.amjcard.2008.09.007","article-title":"Drug-eluting stents and antiplatelet resistance.","volume":"102","author":"Simon","year":"2008","journal-title":"Am J Cardiol"},{"key":"R42-1-20210126","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jacc.2008.06.038","article-title":"Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.","volume":"52","author":"Patti","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R43-1-20210126","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.","volume":"29","author":"Price","year":"2008","journal-title":"Eur Heart J"},{"key":"R44-1-20210126","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.","volume":"51","author":"Trenk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R45-1-20210126","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2007.12.044","article-title":"Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.","volume":"51","author":"Bonello","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R46-1-20210126","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"R47-1-20210126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","article-title":"Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.","volume":"154","author":"Snoep","year":"2007","journal-title":"Am Heart J"},{"key":"R47A-1-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.amjcard.2008.08.048","article-title":"Tailored clopidrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis.","volume":"103","author":"Bonello","year":"2009","journal-title":"Am J Coll Cardiol"},{"key":"R48-1-20210126","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","article-title":"Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"key":"R49-1-20210126","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/eurheartj\/ehi877","article-title":"Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease.","volume":"27","author":"Jernberg","year":"2006","journal-title":"Eur Heart J"},{"key":"R50-1-20210126","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.","volume":"50","author":"Storey","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R51-1-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0953710021000024402","article-title":"Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.","volume":"13","author":"Storey","year":"2002","journal-title":"Platelets"},{"key":"R53-1-20210126","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"R54-1-20210126","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2008.04.002","article-title":"Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.","volume":"51","author":"Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R55-1-20210126","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","article-title":"Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38.","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"R56-1-20210126","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(08)60422-5","article-title":"Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.","volume":"371","author":"Wiviott","year":"2008","journal-title":"Lancet"},{"key":"R57-1-20210126","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2007.11.057","article-title":"Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events.","volume":"101","author":"Bowry","year":"2008","journal-title":"Am J Cardiol"},{"key":"R58-1-20210126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R59-1-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjmed.2007.10.002","article-title":"Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.","volume":"121","author":"Berger","year":"2008","journal-title":"Am J Med"},{"key":"R60-1-20210126","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review.","volume":"297","author":"Campbell","year":"2007","journal-title":"JAMA"},{"key":"R61-1-20210126","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.CIR.0000091201.39590.CB","article-title":"Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.","volume":"108","author":"Peters","year":"2003","journal-title":"Circulation"},{"key":"R62-1-20210126","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2008.07.026","article-title":"Design and rationale of CURRENT-OASIS 7: a randomized, 2 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.","volume":"156","author":"Mehta","year":"2008","journal-title":"Am Heart J"},{"key":"R63-1-20210126","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jacc.2008.08.031","article-title":"Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis.","volume":"52","author":"Berger","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R64-1-20210126","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.athoracsur.2004.03.028","article-title":"Does clopidogrel increase blood loss following coronary artery bypass surgery?","volume":"78","author":"Chu","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"R65-1-20210126","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1185\/030079904X2060","article-title":"The effect of preoperative antiplatelet therapy in coronary artery surgery: blood transfusion requirements for patients on cardiopulmonary bypass.","volume":"20","author":"Hekmat","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R66-1-20210126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0735-1097(02)01954-X","article-title":"The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting.","volume":"40","author":"Hongo","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R67-1-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2006.04.029","article-title":"Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.","volume":"48","author":"Mehta","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R68-1-20210126","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/hrt.2004.058396","article-title":"Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis.","volume":"92","author":"Purkayastha","year":"2006","journal-title":"Heart"},{"key":"R69-1-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejcts.2008.02.024","article-title":"Guideline on antiplatelet and anticoagulation management in cardiac surgery.","volume":"34","author":"Dunning","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"R70-1-20210126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1540-8191.2006.00315.x","article-title":"A cost analysis of nonelective coronary artery bypass graft surgery.","volume":"21","author":"Violette","year":"2006","journal-title":"J Card Surg"},{"key":"R71-1-20210126","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.athoracsur.2005.09.079","article-title":"Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994\u20132003.","volume":"81","author":"Haan","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"R72-1-20210126","doi-asserted-by":"crossref","first-page":"I477","DOI":"10.1161\/CIRCULATIONAHA.105.001545","article-title":"Emergency coronary artery bypass graft surgery for acute coronary syndrome: beating heart versus conventional cardioplegic cardiac arrest strategies.","volume":"114","author":"Rastan","year":"2006","journal-title":"Circulation"},{"key":"R74-1-20210126","doi-asserted-by":"crossref","first-page":"326","DOI":"10.18553\/jmcp.2007.13.4.326","article-title":"Pharmacoeconomic analysis of clopidogrel in secondary prevention of coronary artery disease.","volume":"13","author":"Cheng","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"R75-1-20210126","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2165\/00019053-200725120-00007","article-title":"Oral antiplatelet therapy in secondary prevention of cardiovascular events: an assessment from the payer's perspective.","volume":"25","author":"Heeg","year":"2007","journal-title":"Pharmacoeconomics"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HPC.0b013e31819a442a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:11Z","timestamp":1786038851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00132577-200906000-00001"}},"subtitle":["Indications, Results, Obstacles"],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0b013e31819a442a","relation":{},"ISSN":["1535-282X"],"issn-type":[{"value":"1535-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}